obesity drug
The latest news about obesity drug: headlines, AI summaries and the full story from every source.
- Novo Nordisk's Experimental Obesity Drug Shows Significant Weight Loss in Women
- Novo Nordisk Expands Obesity Drug to Children Amid Market Hesitation
- Eli Lilly Delays Approval Filing for Obesity Drug Retatrutide Until Q1 2027
- Eli Lilly's Retatrutide Shows Promising Results in Weight Loss Trials
- Eli Lilly's Retatrutide Shows Strong Phase 3 Results in Obesity Trial
- Lexicon Pharma and Novo Nordisk Initiate Phase 1 Study for Obesity Drug LX9851
- Eli Lilly's Obesity Pill Shows Strong Initial Performance; OpenAI Launches New Drug Discovery AI Tool